Found: 13
Select item for more details and to access through your institution.
Signatures of T Cells as Correlates of Immunity to Francisella tularensis.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0032367
- By:
- Publication type:
- Article
Identification of Genes Contributing to the Virulence of Francisella tularensis SCHU S4 in a Mouse Intradermal Infection Model.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005463
- By:
- Publication type:
- Article
Parvimonas micra is associated with tumour immune profiles in molecular subtypes of colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 10, p. 2565, doi. 10.1007/s00262-022-03179-4
- By:
- Publication type:
- Article
Tumour Colonisation of Parvimonas micra Is Associated with Decreased Survival in Colorectal Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5937, doi. 10.3390/cancers14235937
- By:
- Publication type:
- Article
A Detailed Flow Cytometric Analysis of Immune Activity Profiles in Molecular Subtypes of Colorectal Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3440, doi. 10.3390/cancers12113440
- By:
- Publication type:
- Article
Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 923, doi. 10.3390/cancers12040923
- By:
- Publication type:
- Article
Parvimonas micra forms a distinct bacterial network with oral pathobionts in colorectal cancer patients.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05720-8
- By:
- Publication type:
- Article
A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62129-1
- By:
- Publication type:
- Article
Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72132-1
- By:
- Publication type:
- Article
Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 2, p. 327, doi. 10.1002/ijc.32104
- By:
- Publication type:
- Article
Cancer-associated fecal microbial markers in colorectal cancer detection.
- Published in:
- International Journal of Cancer, 2017, v. 141, n. 12, p. 2528, doi. 10.1002/ijc.31011
- By:
- Publication type:
- Article
Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer – possible implications for immunotherapy.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 1, p. 143, doi. 10.1038/s41416-023-02483-9
- By:
- Publication type:
- Article
Porphyromonas gingivalis in Colorectal Cancer and its Association to Patient Prognosis.
- Published in:
- Journal of Cancer, 2023, v. 14, n. 9, p. 1479, doi. 10.7150/jca.83395
- By:
- Publication type:
- Article